CTRI/2023/05/052805尚未招募Unknown
Management of anaemia in pregnancy using test and treat strategy: a community based open randomised study
utrition Foundation of India0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Apparently healthy pregnant women
- •No history of systemic or obstetric problems;
- •Not received any iron fortified salt or IFA supplementation in the last six months;
- •Willing to take the supplementation provided through random allocation;
- •Willing to provide information every fortnight on regularity of tablet consumption and side-effects (separately for iron, folic acid/ vitamin B complex);
- •Willing to provide blood sample at enrolment, 12 weeks later and at 38 weeks of pregnancy;
- •Continue taking the supplements till delivery
排除标准
- •not willing to participate in the study, take the supplements given and/or give blood sample;
- •has known systemic or obstetric problems;
- •not likely to reside in the area even for one year
研究者
相似试验
已完成
4 期
Intravenous Treatment of Anemia in PregnancyAnemiaNCT03317210University of Zurich50
已完成
不适用
Non-invasive Point-Of-Care Hemoglobin Testing In An Obstetric PopulationPregnancy AnemiaNCT06521840Beth Israel Deaconess Medical Center124
招募中
Unknown
Study on hemoglobin levels for anemia during pregnancy and postpartum.CTRI/2023/03/050450Centre for Health Research and Development Society for Applied Studies
进行中（未招募）
2 期
Should we treat iron deficiency anaemia of pregnancy with lactoferrin? A randomised controlled trialLactoferrin Evaluation in Anaemia in PregnancyIron Deficient Anaemia in PregnancyReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Childbirth and postnatal careDiet and Nutrition - Other diet and nutrition disordersACTRN12614000988651niversity of Sydney907
招募中
1 期
Phase 2 Study of Luspatercept in Adults and Adolescents with Alpha (a)-thalassemiaAlpha (a)-thalassemiaMedDRA version: 20.1Level: LLTClassification code: 10054659Term: Thalassemia alpha Class: 10010331CTIS2022-502328-35-00Celgene Corp.177